Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2025 ARTÍCULOS , VIENDO DEL 1966 AL 1980

Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease

Lim D, Matute C, Cavaliere F, Verkhratsky A.

Handb Clin Neurol. 2025;210:9-44. doi: 10.1016/B978-0-443-19102-2.00012-0.

Using Single-Cell RNA sequencing with Drosophila, Zebrafish, and mouse models for studying Alzheimer's and Parkinson's disease

Lau F, Binacchi R, Brugnara S, Cumplido-Mayoral A, Savino SD, Khan I, Orso A, Sartori S, Bellosta P, Carl M, Poggi L, Provenzano G.

Neuroscience. 2025 May 7;573:505-517. doi: 10.1016/j.neuroscience.2025.03.042. Epub 2025 Mar 26.

Mitochondrial DNA copy number and Alzheimer's disease and Parkinson disease

Qin P, Chen X, Ma P, Li X, Lin Y, Liu X, Liang X, Qin T, Liang J, Ouyang J.

Mitochondrion. 2025 Jul;83:102032. doi: 10.1016/j.mito.2025.102032. Epub 2025 Mar 27.

The role of semaphorin 3A in the pathogenesis and progression of Alzheimer's disease and other aging-related diseases: A comprehensive review

Yuan J, Huang R, Nao J, Dong X.

Pharmacol Res. 2025 May;215:107732. doi: 10.1016/j.phrs.2025.107732. Epub 2025 Apr 11.

RNA-Based Therapies for Neurodegenerative Diseases Targeting Pathogenic Proteins

Rabbani SA, El-Tanani M, Sharma S, El-Tanani Y, Kumar R, Saini M, Yadav M, Khan MA, Parvez S.

Eur J Neurosci. 2025 Apr;61(8):e70110. doi: 10.1111/ejn.70110.

Plant-Based Therapies to Ameliorate Neuroinflammation in Parkinson's Disease, Alzheimer's Disease, and Epilepsy: A Narrative Review

Sharma D, Rajbongshi B, Isphak T, Basumatary S, Dutta K, Rudrapal M, Goswami AK.

Chem Biodivers. 2025 Sep;22(9):e202500038. doi: 10.1002/cbdv.202500038. Epub 2025 May 20.

Exosome-Mediated Mitochondrial Regulation: A Promising Therapeutic Tool for Alzheimer's Disease and Parkinson's Disease

Jung YH, Jo HY, Kim DH, Oh YJ, Kim M, Na S, Song HY, Lee HJ.

Int J Nanomedicine. 2025 Apr 17;20:4903-4917. doi: 10.2147/IJN.S513816. eCollection 2025.

Longitudinal comparative analysis of antidepressants and anti-anxiety medications in Alzheimer's and Parkinson's diseases: insights from French and British health records

Hamieh N, Ansart M, Guinebretiere O, Lekens B, Gantzer L, Durrleman S, Nedelec T.

J Affect Disord. 2025 Aug 1;382:148-153. doi: 10.1016/j.jad.2025.04.094. Epub 2025 Apr 20.

Brain photobiomodulation: a potential treatment in Alzheimer's and Parkinson's diseases

Blivet G, Touchon B, Cavadore H, Guillemin S, Pain F, Weiner M, Sabbagh M, Moro C, Touchon J.

J Prev Alzheimers Dis. 2025 Aug;12(7):100185. doi: 10.1016/j.tjpad.2025.100185. Epub 2025 Apr 25.

Cholinergic therapy in Alzheimer disease

Gauthier S, Therriault J, Rosa-Neto P.

Handb Clin Neurol. 2025;211:155-159. doi: 10.1016/B978-0-443-19088-9.00015-9.

CNS muscarinic receptors and muscarinic receptor agonists in Alzheimer disease treatment

Fisher A, Levey AI.

Handb Clin Neurol. 2025;211:161-184. doi: 10.1016/B978-0-443-19088-9.00016-0.

Comparative mapping of single-cell transcriptomic landscapes in neurodegenerative diseases

Shwab EK, Man Z, Gingerich DC, Gamache J, Garrett ME, Serrano GE, Beach TG, Crawford GE, Ashley-Koch AE, Chiba-Falek O.

Alzheimers Dement. 2025 May;21(5):e70012. doi: 10.1002/alz.70012.

Advances in biosensors for diagnosis of Alzheimer's and Parkinson's diseases

Negahdary M, Sakthinathan I, Mirsadoughi E, Ligler FS, Coté GL, Forster RJ, Mabbott S.

Biosens Bioelectron. 2025 Sep 15;284:117535. doi: 10.1016/j.bios.2025.117535. Epub 2025 May 2.

Influence of co-pathology on CSF and plasma synaptic markers SNAP25 and VAMP2 in Alzheimer's disease and Parkinson's disease

Gaetani L, Bellomo G, Chiasserini D, De Rocker C, Goossens J, Paolini Paoletti F, Vanmechelen E, Parnetti L.

Alzheimers Res Ther. 2025 May 22;17(1):115. doi: 10.1186/s13195-025-01762-2.

The silent saboteur: oxidative stress and the path to cognitive dysfunction

Garcia TFM, Desio JAF, de Souza EF, Henkes SFC, Santos LS, de Carvalho Muenho J, Gonçalves CL, Dos Santos JCC.

Neurodegener Dis Manag. 2025 Aug;15(4):121-148. doi: 10.1080/17582024.2025.2510175. Epub 2025 May 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias